Order results by:
| Issue | Title | |
| Vol 2, No 2 (2010) | Clinical experience in using cereton in ischemic stroke and dyscirculatory encephalopathy | Abstract similar documents |
| L. P. Ponomareva, N. F. Timoshkina, L. N. Sarantseva, A. A. Bulanov | ||
| "... функций у больных с ИИ и ДЭ широко используется холина альфосцерат - церетон «Сотекс». Цель настоящего ..." | ||
| Vol 3, No 2 (2011) | Use of cereton in neurological care | Abstract similar documents |
| Yu. A. Starchina | ||
| "... . Анализируются возможности применения отечественного препарата церетон (холина альфосцерат) при сосудистых ..." | ||
| Vol 3, No 1 (2011) | Clinical experience with Neurox used in patients with cerebrovascular disease | Abstract similar documents |
| N. G. Mayorova, V. A. Pavlov | ||
| "... ): 10 patients have experienced ischemic stroke and 22 have suffered from dyscirculatory encephalopathy ..." | ||
| Vol 7, No 1 (2015) | Outpatient management of patients with dyscirculatory encephalopathy | Abstract similar documents |
| V. A. Parfenov, D. V. Neverovsky | ||
| "... There is outpatient hyperdiagnosis of dyscirculatory encephalopathy (DE) frequently masked ..." | ||
| Vol 12, No 2 (2020) | The role of citicoline in the treatment of dyscirculatory encephalopathy and vascular cognitive impairment | Abstract similar documents |
| V. A. Golovacheva | ||
| "... Vascular cognitive impairment (VCI) is the main manifestation of dyscirculatory encephalopathy (DEP ..." | ||
| Vol 8, No 3 (2016) | Diagnosis and treatment of chronic cerebrovascular disease, use of pentoxifylline | Abstract PDF (Eng) similar documents |
| V. A. Parfenov | ||
| "... , so patients do not receive effective treatment. To modify risk factors for stroke (smoking and alcohol ..." | ||
| Vol 6, No 1 (2014) | Vascular cognitive impairment | Abstract similar documents |
| N.V. Vakhnina | ||
| Vol 1, No 2 (2009) | DEPRESSION IN CEREBROVASCULAR DISEASES | Abstract similar documents |
| T. G. Voznesenskaya | ||
| "... data on the prevalence of depression in dyscirculatory encephalopathy with non-dementia cognitive ..." | ||
| Vol 7, No 4 (2015) | Possibilities of using naftidrofuryl in the therapy of cerebrovascular diseases: Literature review and the authors’ observations | Abstract similar documents |
| A. N. Belova, D. N. Shakurova, E. V. Gayazova | ||
| "... of naftidrofuryl used in patients with dyscirculatory encephalopathy, which have confirmed its efficacy ..." | ||
| Vol 15, No 4 (2023) | The role of trimethylamine-N-oxide in the development of cerebrovascular disease (brief review) | Abstract similar documents |
| M. A. Kutlubaev, A. R. Rakhmatullin, R. F. Kutlubaeva | ||
| "... . It increases the risk of stroke and dyscirculatory encephalopathy, independent of traditional cardiovascular ..." | ||
| 1 - 10 of 10 Items | ||
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)







































